Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ST6GAL1 | P15907 | 7/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.45 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.43 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18074931 | 1.00 | ST6GAL1 (0.47) | ST6GAL1CYP3A4CYP2C9P2RY12P2RY2 | |
| SCHEMBL18089637 | 0.93 | CYP3A4 (0.54) | ST6GAL1CYP3A4CYP2C9P2RY12P2RY2 | |
| SCHEMBL20668732 | 0.93 | CYP3A4 (0.54) | ST6GAL1CYP3A4CYP2C9P2RY12P2RY2 | |
| SCHEMBL18074917 | 0.93 | ST6GAL1 (0.46) | ST6GAL1CYP3A4CYP2C9P2RY12P2RY2 | |
| SCHEMBL19923818 | 0.93 | ST6GAL1 (0.46) | ST6GAL1CYP3A4CYP2C9P2RY12P2RY2 | |
| SCHEMBL18074927 | 0.91 | ST6GAL1 (0.45) | ST6GAL1CYP3A4CYP2C9P2RY12P2RY2 | |
| SCHEMBL19923835 | 0.91 | ST6GAL1 (0.45) | ST6GAL1CYP3A4CYP2C9P2RY12P2RY2 | |
| SCHEMBL18089396 | 0.90 | ST6GAL1 (0.43) | ST6GAL1CYP3A4CYP2C9P2RY12P2RY2 | |
| SCHEMBL21546326 | 0.90 | ST6GAL1 (0.43) | ST6GAL1CYP3A4CYP2C9P2RY12P2RY2 | |
| SCHEMBL18089624 | 0.89 | ST6GAL1 (0.42) | ST6GAL1CYP3A4CYP2C9P2RY12P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3271468-B1 | DEAMINATION OF ORGANOPHOSPHORUS-NUCLEOSIDES | LABORATORIO TECNICO DE SEGURIDAD Y ESTANDARIZACION SL (ES) | 2022-12-14 | — | — | EP | disclosed |
| US-20180066295-A1 | DEAMINATION OF ORGANOPHOSPHORUS-NUCLEOSIDES | LABORATORIO TECNICO DE SEGURIDAD Y ESTANDARIZACION, S.L.U. (ES) | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180066295-A1 | DEAMINATION OF ORGANOPHOSPHORUS-NUCLEOSIDES | ADA, CDA, DCTD | ST6GAL1 1667/4885CYP3A4 217/4885CYP2C9 180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.